Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (81-90 of 172) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|March 12, 2008
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCTS K Kumar, D Dingli, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapyB Siontis, S Kumar, A Dispenzieri, et al.
Blood Cancer Journal|February 14, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
Pageof 18

Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|March 12, 2008
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCTS K Kumar, D Dingli, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapyB Siontis, S Kumar, A Dispenzieri, et al.
Blood Cancer Journal|February 14, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia & Lymphoma|May 9, 2001
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosisR Fonseca, S V Rajkumar, G J Ahmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Leukemia|March 22, 2013
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myelomaS V Rajkumar, V Gupta, R Fonseca, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Bone Marrow Transplantation|July 1, 2008
Impact of early relapse after auto-SCT for multiple myelomaS Kumar, S T Mahmood, M Q Lacy, et al.
Leukemia|August 2, 2001
Thalidomide for previously untreated indolent or smoldering multiple myelomaS V Rajkumar, A Dispenzieri, R Fonseca, et al.
American Journal of Clinical Oncology|April 13, 1999
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent gliomaS V Rajkumar, P A Burch, S Nair, et al.
Pageof 18